TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug...
28 insider purchases on record · latest filing 2026-05-18.
Insiders have also filed 22 sale transactions at TLSI.